Programmed cell death receptor 1 ligand 1 (PD-L1) expression in various tumors, including hematologic malignancies, has recently become a research topic of great interest. | The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma A metaanalysis